Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap7.58B
Enterprise Value8.27B
Trailing P/E44.88
BIO
(NYSE)Bio-Rad Laboratories, Inc.
$287.86-- (--)
Loading... - Market loading
Bio-Rad Laboratories (BIO) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)2.93
Forward Price/Sales2.87
Price/Book (mrq)1.11
Price/Tangible Book (mrq)1.24
Price/FCF (ttm)21.21
Price/OCF (ttm)14.84
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue3.19
EV/Earnings49.01
EV/EBITDA14.27
EV/EBIT10.91
EV/FCF23.16
Stock Price
Current price, 52-week range, and moving averages
Current Price$287.86
1-Day Change2.42%
52-Week High$343.12
52-Week Low$211.43
52-Week Change-5.02%
YTD Change-5.70%
1-Year Change26.27%
50-Day MA$274.51
200-Day MA$292.35
Avg Volume (30 day)398.30K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding26.96M
Book Value per Share$254.15
Net Cash per Share$-25.83
FCF per Share$13.25
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$300.00
Target Upside/Downside4.22%
Analyst ConsensusHold
Analyst Count1
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin51.85%
EBITDA Margin (ttm)22.38%
EBIT Margin (ttm)29.28%
Operating Margin (ttm)9.10%
Pretax Margin (ttm)8.58%
Profit Margin (ttm)6.52%
FCF Margin (ttm)13.79%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)2.46%
Return on Assets (ttm)1.72%
Return on Invested Capital (ttm)7.63%
Return on Capital Employed (ttm)8.55%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue2.59B
Gross Profit1.34B
Operating Income235.60M
Pretax Income222.30M
Net Income168.80M
EBITDA579.60M
EBIT758.40M
Diluted EPS$6.24
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow510.40M
Capital Expenditures153.20M
Free Cash Flow357.20M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth1.92%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)9.79B
Cash & Securities (mrq)507.20M
Net Cash (mrq)-696.20M
Net Cash per Share$-25.83
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)1.20B
Working Capital (mrq)2.03B
Total Equity (mrq)6.85B
Book Value per Share$254.15
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)3.21
Quick Ratio (mrq)2.37
Debt/Equity (mrq)0.18
Debt/EBITDA (ttm)2.08
Debt/FCF (ttm)3.37
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield2.23%
FCF Yield4.71%
Buyback Yield3.07%
Total Shareholder Yield3.07%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score3.41
Piotroski F-Score4/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$188.97
Graham Upside/Downside-34.35%
Frequently Asked Questions About Bio-Rad Laboratories Statistics
What are the key financial metrics for BIO?
Bio-Rad Laboratories, Inc. (BIO) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is BIO's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Bio-Rad Laboratories is overvalued or undervalued.
How do I read BIO's profitability ratios?
Bio-Rad Laboratories's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do BIO's debt ratios indicate?
The financial health section shows Bio-Rad Laboratories's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is BIO's dividend analysis?
The dividend section covers Bio-Rad Laboratories's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.